CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ (9,002)	$ 61,060
Adjustments to net income (loss):
Depreciation and amortization	157,685	163,031
Deferred income tax expense (benefit)	6,376	4,713
Impairments and other charges		5,318
Amortization of debt discount and deferred financing costs	2,266	2,020
Losses (gains) on debt buyback	2,576	(24,856)
Losses (gains) on long-lived assets, net	4,600	337
Losses (gains) on investments, net	(10)	(354)
Share-based compensation	4,155	3,980
Foreign currency transaction losses (gains), net	11,394	6,454
Mark-to-market (gain) loss on warrants	(5,679)	(34,565)
Other	553	47
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(67,201)	19,223
Inventory	(2,046)	(16,272)
Other current assets	(2,548)	6,726
Other long-term assets	665	(5,458)
Trade accounts payable and accrued liabilities	8,625	(47,375)
Income taxes payable	3,810	9,952
Other long-term liabilities	(8,980)	69
Net cash provided by (used for) operating activities	107,239	154,050
Cash flows from investing activities:
Purchases of investments	(7,544)	(11,385)
Capital expenditures	(104,627)	(118,734)
Proceeds from sales of assets	5,502	1,982
Other	40	6
Net cash (used for) provided by investing activities	(106,629)	(128,131)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		250,000
Reduction in long-term debt	(631,043)	(232,549)
Debt issuance costs	(1,343)	(7,870)
Proceeds from revolving credit facilities	75,000	85,000
Reduction in revolving credit facilities	(75,000)	(85,000)
Payments for employee taxes on net settlement of equity awards	(2,634)	(7,071)
Dividends to common and preferred shareholders	(87)	(194)
Net cash (used for) provided by financing activities	(635,107)	2,316
Effect of exchange rate changes on cash and cash equivalents	(5,910)	(3,846)
Net increase (decrease) in cash and cash equivalents and restricted cash	(640,407)	24,389
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents and restricted cash, end of period	733,775	761,529
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	1,057,487	451,025
Restricted cash, beginning of period	316,695	286,115
Cash and cash equivalents and restricted cash, beginning of period	1,374,182	737,140
Cash and cash equivalents, end of period	412,864	469,438
Restricted cash, end of period	$ 320,911	$ 292,091
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 733,775	$ 761,529